Shawn Kile is a Neurology physician affiliated with Sutter Medical Center. OpenAlex indexes 23 publications with 1,038 citations (h-index 12); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2315 Stockton Blvd
Sacramento, CA 958172201
Telephone
916-734-3415Registry record last updated 27 Jul 2015.
Clinical trials
- Effect of LEQEMBI on Cerebral and Retinal Amyloid in Mild Cognitive Impairment Due to Alzheimer's Disease
Sponsor: NeuroVision Imaging
- Study of Intravenous Immunoglobulin in Amnestic Mild Cognitive Impairment
Sponsor: Sutter Health
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
97.7%Cholinesterase Inhibitor34.4%Galantamine Er44%Donepezil Hcl32%Rivastigmine11%Galantamine Hbr11%Exelon2%Part D<11 patientsN-methyl-D-aspartate Receptor Antagonist24%Memantine Hcl Er60%Memantine Hcl40%Part D≥111 patients+ 15 more classes in this area
Blood & clotting
1.3%P2Y12 inhibitor1.3%Clopidogrel100%Part D≥11 patientsCardiovascular
0.6%Beta blocker0.6%Propranolol Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Patient Characteristics and Safety of Lecanemab in a Large Community‐Based Cohort at Sutter Health
Alzheimer s & Dementia
2025 - Reduction of Amyloid in the Brain and Retina After Treatment With IVIG for Mild Cognitive Impairment
American Journal of Alzheimer s Disease & Other Dementias®
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Mark Leibenhaut, MD
Sutter Medical Center
Dmitri Gelfand, MD
Sutter Medical Center
Rudolph Schrot, MD
Sutter Medical Center
Monica Lawry, MD
Sutter Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”